J. Mazarati

发表

A sister lineage of the Mycobacterium tuberculosis complex discovered in the African Great Lakes region

S. Duthoy, L. Rigouts, B. D. de Jong, 2020, Nature Communications.

A sister lineage of the Mycobacterium tuberculosis complex discovered in the African Great Lakes region

S. Duthoy, L. Rigouts, B. D. de Jong, 2020, Nature Communications.

Induction of replicative senescence biomarkers by sublethal oxidative stresses in normal human fibroblast.

J. Remacle, Q. Chen, P. Dumont, 2000, Free radical biology & medicine.

A pooled testing strategy for identifying SARS-CoV-2 at low prevalence

N. Turok, W. Ndifon, J. Souopgui, 2020, Nature.

Rwanda 20 years on: investing in life

C. Karema, J. Mukherjee, E. Karita, 2014, The Lancet.

CHEK2 Germ Line Mutations are Lacking among Familial and Sporadic Breast Cancer Patients in Rwanda

M. Mzibri, Y. Bakri, J. Mazarati, 2018, Asian Pacific journal of cancer prevention : APJCP.

Association between glutathione peroxidase 1 codon 198 variant and the occurrence of breast cancer in Rwanda

Y. Bakri, J. Mazarati, Thierry Habyarimana, 2018, Molecular genetics & genomic medicine.

Prevalence and drivers of false-positive rifampicin-resistant Xpert MTB/RIF results: a prospective observational study in Rwanda.

L. Rigouts, W. B. de Rijk, B. D. de Jong, 2020, The Lancet. Microbe.

Characterisation of Staphylococci species from neonatal blood cultures in low- and middle-income countries

J. Mathias, R. K. Nandy, A. Whitelaw, 2022, BMC Infectious Diseases.

Antibiotic resistance genes in the gut microbiota of mothers and linked neonates with or without sepsis from low- and middle-income countries

J. Mathias, A. Whitelaw, T. Walsh, 2022, Nature Microbiology.

Examining the early distribution of the artemisinin-resistant Plasmodium falciparum kelch13 R561H mutation in Rwanda

J. Bailey, C. Karema, O. Watson, 2022, bioRxiv.

Effects of antibiotic resistance, drug target attainment, bacterial pathogenicity and virulence, and antibiotic access and affordability on outcomes in neonatal sepsis: an international microbiology and drug evaluation prospective substudy (BARNARDS)

J. Mathias, R. K. Nandy, A. Whitelaw, 2021, The Lancet. Infectious diseases.

Neonatal sepsis and mortality in low-income and middle-income countries from a facility-based birth cohort: an international multisite prospective observational study

K. Hood, J. Mathias, D. Gillespie, 2022, The Lancet. Global health.

A multinational Delphi consensus to end the COVID-19 public health threat

Manfred S. Green, Bary S. R. Pradelski, LeAnne K. Robinson, 2022, Nature.

Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda

D. Fidock, E. Legrand, D. Ménard, 2020, Nature Medicine.

Spatio-temporal distribution of mosquitoes and risk of malaria infection in Rwanda.

Willem Takken, Agnes Binagwaho, Emmanuel Hakizimana, 2018, Acta tropica.

Association of p53 Codon 72 Polymorphism with Breast Cancer in a Rwandese Population

Y. Bakri, J. Mazarati, Thierry Habyarimana, 2017, Pathobiology.

A Randomized Switch From Nevirapine-Based Antiretroviral Therapy to Single Tablet Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate in Virologically Suppressed Human Immunodeficiency Virus-1-Infected Rwandans

A. Zolopa, P. Grant, S. Nsanzimana, 2016, Open forum infectious diseases.

A Worldwide Map of Plasmodium falciparum K13-Propeller Polymorphisms.

C. Rogier, D. Fidock, B. Pradines, 2016, The New England journal of medicine.

Detection of human papillomavirus DNA in tumors from Rwandese breast cancer patients

Y. Bakri, J. Mazarati, Thierry Habyarimana, 2018, Breast Cancer.

Single-Molecule Real-Time (SMRT) Full-Length RNA-Sequencing Reveals Novel and Distinct mRNA Isoforms in Human Bone Marrow Cell Subpopulations

P. Baybayan, R. Sebra, E. Tseng, 2019, bioRxiv.

Single molecule real time (SMRT) full length RNA-sequencing reveals novel and distinct mRNA isoforms in human bone marrow cell subpopulations

P. Baybayan, R. Sebra, E. Tseng, 2019, bioRxiv.

Characterization of antimicrobial-resistant Gram-negative bacteria that cause neonatal sepsis in seven low- and middle-income countries

K. Hood, J. Mathias, D. Gillespie, 2021, Nature Microbiology.

Leapfrogging with technology: introduction of a monitoring platform to support a large-scale Ebola vaccination program in Rwanda

E. Karita, A. De Paepe, J. Mazarati, 2021, Human vaccines & immunotherapeutics.

Monitoring of Adverse Events in Recipients of the 2-Dose Ebola Vaccine Regimen of Ad26.ZEBOV Followed by MVA-BN-Filo in the UMURINZI Ebola Vaccination Campaign

E. Karita, S. Allen, S. Nsanzimana, 2022, The Journal of infectious diseases.

A strategy for finding people infected with SARS-CoV-2: optimizing pooled testing at low prevalence

N. Turok, W. Ndifon, L. Mutesa, 2020, medRxiv.

Innovative strategies for a successful SLMTA country programme: The Rwanda story

G. Dahourou, J. Mazarati, J. Serumondo, 2014, African journal of laboratory medicine.

Multidrug-resistant tuberculosis control in Rwanda overcomes a successful clone that causes most disease over a quarter century

L. Rigouts, Cécile Uwizeye, B. D. de Jong, 2022, Journal of clinical tuberculosis and other mycobacterial diseases.

Utility of molecular diagnostic method compared with conventional methods in detection of etiologic agents of central nervous system infections in Rwanda

W. Jaoko, O. Anzala, J. Mazarati, 2019, African Journal of Microbiology Research.

A pooled testing strategy for identifying SARS-CoV-2 at low prevalence

N. Turok, W. Ndifon, L. Mutesa, 2020, Nature.

Highly successful treatment outcome of multidrug‐resistant and genetic diversity of multidrug‐resistant Mycobacterium tuberculosis strains in Rwanda

Eric Seruyange, J. S. Ngabonziza, J. Mazarati, 2019, Tropical medicine & international health : TM & IH.

Examining the Early Distribution of the Artemisinin-Resistant Plasmodium falciparum kelch13 R561H Mutation in Areas of Higher Transmission in Rwanda

J. Bailey, C. Karema, O. Watson, 2023, Open Forum Infectious Diseases.

Reduction of diagnostic and treatment delays reduces rifampicin-resistant tuberculosis mortality in Rwanda.

L. Rigouts, C. Meehan, D. Affolabi, 2020, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Shaping the future of global access to safe, effective, appropriate and quality health products

P. Srinivas, R. van de Pas, W. Van Damme, 2024, BMJ Global Health.

Author Correction: Emergence and clonal expansion of in vitro artemisinin-resistant Plasmodium falciparum kelch13 R561H mutant parasites in Rwanda

D. Fidock, E. Legrand, D. Ménard, 2021, Nature Medicine.

High frequency of artemisinin partial resistance mutations in the great lake region revealed through rapid pooled deep sequencing

C. Karema, D. Ishengoma, J. Mazarati, 2024, medRxiv.

Expansion of artemisinin partial resistance mutations and lack of histidine rich protein-2 and -3 deletions in Plasmodium falciparum infections from Rukara, Rwanda

C. Karema, J. Mazarati, C. Muvunyi, 2023, medRxiv.

Colonisation of hospital surfaces from low- and middle-income countries by extended spectrum β-lactamase- and carbapenemase-producing bacteria

J. Mathias, J. Mazarati, R. Zahra, 2024, Nature communications.

Challenges in diagnosis of Central Nervous System infections using Conventional Method: Need for better approach in Rwanda

W. Jaoko, O. Anzala, J. Mazarati, 2017 .

Using digital tools and antigen rapid testing to support household-level SARS-CoV-2 detection by community health workers in Rwanda: an operational pilot study

J. S. Ngabonziza, J. Mazarati, M. Semakula, 2024, BMJ open.